MedPath

Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.

Terminated
Conditions
Parkinson Disease
Interventions
Behavioral: behavioral observation
Registration Number
NCT02894333
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

The ideomotor theory of action control is considered to be central to the understanding of human voluntary action. According to the ideomotor theory, an action is represented in terms of its desired sensory effects and actions are selected by internally activating these effect representations. Recent imagery and behavioral studies showed that this anticipated representation of action-effects triggered a "sensory attenuation", meaning a decrease of perceptive performances or a decrease of sensory event-related potentials (ERP) for an expected event. Thus, the sensory attenuation constitutes a relevant behavioral tool to investigate sensory anticipation impairment in patients with Parkinson's disease. In a behavioral paradigm, patients and matched control participants have to perform a perceptive task on predicted visual action-effects mixed with mispredicted visual action effects. Performances should be better in mispredicted visual action effects for control participants only.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Parkinson's disease
  • Normal or corrected vision
Exclusion Criteria
  • Other pathology or neurological or psychiatric history
  • Known pregnancy or breastfeeding
  • Absence of affiliation to the French Social Security
  • Person under legal protection
  • Patient's opposition to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Parkinson's diseasebehavioral observation-
Primary Outcome Measures
NameTimeMethod
median scorebaseline

scores measured with the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Fondation Adolphe de Rothschild

🇫🇷

Paris, France

Fondation Ophtalmologique Adolphe de Rothschild

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath